| pubmed-article:21039413 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21039413 | lifeskim:mentions | umls-concept:C0021758 | lld:lifeskim |
| pubmed-article:21039413 | lifeskim:mentions | umls-concept:C0016030 | lld:lifeskim |
| pubmed-article:21039413 | lifeskim:mentions | umls-concept:C0250604 | lld:lifeskim |
| pubmed-article:21039413 | lifeskim:mentions | umls-concept:C0011615 | lld:lifeskim |
| pubmed-article:21039413 | lifeskim:mentions | umls-concept:C0221928 | lld:lifeskim |
| pubmed-article:21039413 | lifeskim:mentions | umls-concept:C0221198 | lld:lifeskim |
| pubmed-article:21039413 | lifeskim:mentions | umls-concept:C1332676 | lld:lifeskim |
| pubmed-article:21039413 | lifeskim:mentions | umls-concept:C0205178 | lld:lifeskim |
| pubmed-article:21039413 | lifeskim:mentions | umls-concept:C0333348 | lld:lifeskim |
| pubmed-article:21039413 | lifeskim:mentions | umls-concept:C0205217 | lld:lifeskim |
| pubmed-article:21039413 | lifeskim:mentions | umls-concept:C1948023 | lld:lifeskim |
| pubmed-article:21039413 | lifeskim:mentions | umls-concept:C0870432 | lld:lifeskim |
| pubmed-article:21039413 | lifeskim:mentions | umls-concept:C1705417 | lld:lifeskim |
| pubmed-article:21039413 | lifeskim:mentions | umls-concept:C1555465 | lld:lifeskim |
| pubmed-article:21039413 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:21039413 | pubmed:dateCreated | 2011-3-7 | lld:pubmed |
| pubmed-article:21039413 | pubmed:abstractText | The presence of eosinophils and/or eosinophil-derived products in the dermis is characteristic for involved skin of patients with atopic dermatitis and contributes to the observed tissue injury. CCL11 is a potent chemoattractant and activator of human eosinophils and interleukin (IL)-4 is a potent inducer of CCL11 expression in dermal fibroblasts. | lld:pubmed |
| pubmed-article:21039413 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21039413 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21039413 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21039413 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21039413 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21039413 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21039413 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21039413 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:21039413 | pubmed:issn | 1365-2133 | lld:pubmed |
| pubmed-article:21039413 | pubmed:author | pubmed-author:ChristophersE... | lld:pubmed |
| pubmed-article:21039413 | pubmed:author | pubmed-author:BartelsJJ | lld:pubmed |
| pubmed-article:21039413 | pubmed:author | pubmed-author:WeichenthalMM | lld:pubmed |
| pubmed-article:21039413 | pubmed:author | pubmed-author:Fölster-Holst... | lld:pubmed |
| pubmed-article:21039413 | pubmed:author | pubmed-author:SchröderJ-MJM | lld:pubmed |
| pubmed-article:21039413 | pubmed:author | pubmed-author:GahrNN | lld:pubmed |
| pubmed-article:21039413 | pubmed:copyrightInfo | © 2011 The Authors. BJD © 2011 British Association of Dermatologists. | lld:pubmed |
| pubmed-article:21039413 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21039413 | pubmed:volume | 164 | lld:pubmed |
| pubmed-article:21039413 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21039413 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21039413 | pubmed:pagination | 586-92 | lld:pubmed |
| pubmed-article:21039413 | pubmed:meshHeading | pubmed-meshheading:21039413... | lld:pubmed |
| pubmed-article:21039413 | pubmed:meshHeading | pubmed-meshheading:21039413... | lld:pubmed |
| pubmed-article:21039413 | pubmed:meshHeading | pubmed-meshheading:21039413... | lld:pubmed |
| pubmed-article:21039413 | pubmed:meshHeading | pubmed-meshheading:21039413... | lld:pubmed |
| pubmed-article:21039413 | pubmed:meshHeading | pubmed-meshheading:21039413... | lld:pubmed |
| pubmed-article:21039413 | pubmed:meshHeading | pubmed-meshheading:21039413... | lld:pubmed |
| pubmed-article:21039413 | pubmed:meshHeading | pubmed-meshheading:21039413... | lld:pubmed |
| pubmed-article:21039413 | pubmed:meshHeading | pubmed-meshheading:21039413... | lld:pubmed |
| pubmed-article:21039413 | pubmed:meshHeading | pubmed-meshheading:21039413... | lld:pubmed |
| pubmed-article:21039413 | pubmed:meshHeading | pubmed-meshheading:21039413... | lld:pubmed |
| pubmed-article:21039413 | pubmed:meshHeading | pubmed-meshheading:21039413... | lld:pubmed |
| pubmed-article:21039413 | pubmed:meshHeading | pubmed-meshheading:21039413... | lld:pubmed |
| pubmed-article:21039413 | pubmed:meshHeading | pubmed-meshheading:21039413... | lld:pubmed |
| pubmed-article:21039413 | pubmed:meshHeading | pubmed-meshheading:21039413... | lld:pubmed |
| pubmed-article:21039413 | pubmed:meshHeading | pubmed-meshheading:21039413... | lld:pubmed |
| pubmed-article:21039413 | pubmed:meshHeading | pubmed-meshheading:21039413... | lld:pubmed |
| pubmed-article:21039413 | pubmed:meshHeading | pubmed-meshheading:21039413... | lld:pubmed |
| pubmed-article:21039413 | pubmed:meshHeading | pubmed-meshheading:21039413... | lld:pubmed |
| pubmed-article:21039413 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21039413 | pubmed:articleTitle | Dermal fibroblasts from acute inflamed atopic dermatitis lesions display increased eotaxin/CCL11 responsiveness to interleukin-4 stimulation. | lld:pubmed |
| pubmed-article:21039413 | pubmed:affiliation | Clinical Research Unit, Department of Dermatology, University Medical Center Schleswig-Holstein, Campus Kiel, Germany. | lld:pubmed |
| pubmed-article:21039413 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21039413 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
